William Hanna Kutteh | Chromosomal Abnormalities | Excellence in Research 

Prof Dr. William Hanna Kutteh | Chromosomal Abnormalities | Excellence in Research 

University of Tennessee HSC and Baptist Women's Hospital | Unites States

Author Profile

Scopus

Google Scholar

🌟 Biography of William Hanna Kutteh, MD, PhD, HCLD, CC 🌟

William Hanna Kutteh is a distinguished physician, scientist, and educator with an exceptional career in reproductive endocrinology, obstetrics, and gynecology. His contributions span across academic research, clinical excellence, and education, solidifying his legacy as a pioneer in reproductive health.

🏛️ EARLY ACADEMIC PURSUITS

William Hanna Kutteh embarked on his academic journey at Wake Forest University, earning a Bachelor of Arts in Biology with a minor in Chemistry (1971-1975). His keen interest in immunology led him to pursue graduate studies at Duke University, where he took advanced courses in immunology under the mentorship of Dr. Jeff Dawson (1975-1978).

He furthered his research with a Ph.D. in Molecular Cell Biology and Immunology from the University of Alabama at Birmingham (1978-1981), mentored by Dr. Jiri Mestecky. Following this, he achieved his MD at the Wake Forest University School of Medicine (1981-1985).

🩺 PROFESSIONAL ENDEAVORS

Key Positions

Dr. Kutteh has held prominent positions across leading institutions:

  • Founding Partner & Director at the Fertility Associates of Memphis
  • Professor of Obstetrics and Gynecology, University of Tennessee Health Sciences Center
  • Clinical Professor, Vanderbilt University Medical Center
  • Consulting Gynecologist, St. Jude Children’s Research Hospital, where he founded the Fertility Preservation Program

Special Roles

  • Director of Reproductive Endocrinology and Infertility at Baptist Memorial Hospital
  • Director of Resident Research Program, fostering the next generation of reproductive specialists
  • Director of EMIGS Simulation Training, advancing minimally invasive gynecologic surgery training

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CHROMOSOMAL ABNORMALITIES

Dr. Kutteh’s research encompasses:

  1. Reproductive Immunology: Exploring immunological causes of recurrent pregnancy loss.
  2. Fertility Preservation: Pioneering techniques for cancer patients.
  3. Endocrine Disorders: Advancing treatments in reproductive endocrinology and infertility.
  4. Minimally Invasive Surgery: Innovating gynecological surgical techniques.

His dedication to translational medicine bridges the gap between laboratory research and clinical application, improving patient outcomes.

🌍 IMPACT AND INFLUENCE

Dr. Kutteh has significantly impacted:

  • Patient Care: As a reproductive endocrinologist, he has transformed the lives of countless families.
  • Medical Education: Training residents and fellows in cutting-edge reproductive techniques.
  • Research: Leading groundbreaking studies funded by the NIH, such as a prestigious R01 grant from the National Institutes of Child Health and Human Development (1995-1999).

📚 ACADEMIC CITATIONS

Dr. Kutteh's scholarly contributions include:

  • Numerous peer-reviewed publications in high-impact journals.
  • Regular faculty roles at national and international conferences such as ASRM, ESHRE, and FASEB, where his expertise in early pregnancy and immunology is widely sought after.
  • Recognition by Newsweek and US News & World Report as one of the top reproductive endocrinologists in America.

🏅 HONORS AND AWARDS

Dr. Kutteh's accolades include:

  • America’s Top Doctors by Castle Connolly (1996-2022)
  • Top Reproductive Endocrinologist by US News & World Report (2012)
  • Louie C. Henry Faculty Award for excellence in clinical teaching (2024)

He has also received numerous Sigma Xi Research Awards and service awards from professional societies, such as the American Society for Reproductive Medicine (ASRM).

💡 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Kutteh’s legacy is marked by his dual commitment to advancing reproductive medicine and mentoring future leaders in the field. His ongoing work in fertility preservation, reproductive immunology, and minimally invasive surgery ensures his enduring influence.

As a visionary, he continues to push the boundaries of reproductive health through research, innovation, and education, shaping a brighter future for patients and practitioners alike.

📑NOTABLE PUBLICATIONS 

"Response: Would surgical retrieval of product of conception for the purpose of genetic analysis increase the risk of intra uterine adhesions?

  • Authors: Kutteh, W.H. , Maisenbacher, M. , Dahdouh, E.M.
  • Journal: Reproductive BioMedicine Online
  • Year: 2024

"Cell-Free DNA Analysis of Fetal Aneuploidies in Early Pregnancy Loss

  • Authors: Kutteh, W.H. , Miller, C.E. , Park, J.K. , Bhatt, S. , Keefe, D.L.
  • Journal: Journal of Clinical Medicine
  • Year: 2024

"Role of genetic analysis of products of conception and PGT in managing early pregnancy loss

  • Authors: Kutteh, W.H. , Papas, R.S. , Maisenbacher, M.K. , Dahdouh, E.M.
  • Journal: Reproductive BioMedicine Online
  • Year: 2024

"Expanding the role of chromosomal microarray analysis in the evaluation of recurrent pregnancy loss

  • Authors: Eliwa, J. , Papas, R.S. , Kutteh, W.H.
  • Journal: Journal of Reproductive Immunology
  • Year: 2024

"Is it time for new guidelines for recurrent pregnancy loss integrating genetic testing of products of conception and preimplantation genetic testing?

  • Authors: Kutteh, W.H. , Papas, R.S. , Dahdouh, E.M.
  • Journal: Fertility and Sterility
  • Year: 2024

Sami Nassar | Cancer Genetics and Genomics | Best Researcher Award

Dr. Sami Nassar | Cancer Genetics and Genomics | Best Researcher Award

Medical University of South Carolina | United States

Author Profile

Orcid ID

🌟 SAMI I. NASSAR: A DEDICATED JOURNEY IN MEDICINE AND RESEARCH

EARLY ACADEMIC PURSUITS 🎓

Sami I. Nassar began his academic journey at Columbia University, where he majored in Neuroscience and Behavior, graduating Cum Laude in 2019 with an impressive GPA of 3.94/4.00. His academic excellence earned him a place in the Psi Chi International Honor Society in Psychology for his outstanding achievements. This strong foundation in neuroscience laid the groundwork for his future medical career. He is currently pursuing his MD at Wayne State University, School of Medicine, where he is on track to graduate in June 2024, having achieved a Step 2 Score of 258—a testament to his dedication to medical excellence.

PROFESSIONAL ENDEAVORS 👨‍⚕️

Throughout his career, Nassar has actively engaged in clinical and research positions across prestigious institutions. His experience as a Research Fellow at the Medical University of South Carolina since 2024 has enabled him to delve into otolaryngological topics, including vertiginous disorders and suicide risk in head and neck cancer patients. At the Henry Ford Health System and Karmanos Cancer Institute, he contributed to significant research on molecular biomarkers and substance use among cancer patients, helping to push the boundaries of cancer research and patient care. His earlier roles, including work at Generation Next Fertility and Columbia University, demonstrate his practical skills in clinical and laboratory settings, offering a holistic approach to patient care and research. These roles also gave him experience in collaborating with medical professionals and managing clinical trials, which have been integral to his development as a medical researcher.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER GENETICS AND GENOMICS 🔬

Nassar’s research has focused heavily on otolaryngology, head and neck cancer, and HPV-related carcinomas. His work on identifying molecular biomarkers and risk factors in cancer patients, such as those for suicide and substance use, has been groundbreaking. His research not only seeks to understand the molecular foundations of cancer but also aims to improve the quality of life for cancer patients. His investigations into tinnitus and vertiginous disorders add further depth to his research portfolio, contributing to patient outcomes in the field of ear, nose, and throat (ENT) medicine.

IMPACT AND INFLUENCE 🏆

Nassar's research has been widely recognized within the medical community, as seen through numerous awards. His work has been presented at leading conferences, such as the American Head and Neck Society's 11th International Conference, where he won the 3rd place poster award in the Education/Care Delivery category. His earlier recognition by the American Journal of Gastroenterology in 2021 further highlights his ability to contribute to diverse fields of medicine. His influence extends to peer-reviewed academic journals, where his manuscripts and abstracts have garnered attention, solidifying his reputation as a promising researcher.

ACADEMIC CITES 📚

Nassar’s work has been cited in reputable journals, including Cancer Epidemiology, Biomarkers & Prevention, and the American Journal of Gastroenterology. His published work on topics like teduglutide therapy for Short Bowel Syndrome and cancer epidemiology reflects his ability to contribute to high-impact scientific literature. These citations, alongside his ongoing manuscripts on suicide and substance use in cancer patients, illustrate his influence on ongoing medical research.

LEGACY AND FUTURE CONTRIBUTIONS 🌍

As a young and promising researcher, Nassar is poised to make even more significant contributions to the field of medicine. His research on biomarkers and immunochemotherapy for cancer treatment, as well as his ongoing investigation into the psychological aspects of cancer care, will likely have a lasting impact on both academic research and clinical practice. His focus on improving patient quality of life through research on mental health and substance use demonstrates his commitment to a holistic approach to medicine, one that integrates both physical and mental health outcomes. His legacy will undoubtedly include shaping future practices in otolaryngology, head and neck oncology, and biomolecular cancer therapy. With his continued drive and dedication, Nassar’s future contributions to medical science promise to push boundaries and pave the way for innovative treatments and care models.

NOTABLE PUBLICATIONS 📑

"S3030 Safety and Efficacy of Teduglutide Therapy for Management of Short Bowel Syndrome After Intestinal Transplantation" 

  • Authors: Sami I. Nassar; Syed-Mohammed Jafri
  • Journal: American Journal of Gastroenterology
  • Year: 2021

"Abstract C067: Disparities in health literacy in patients with head and neck cancer: Considerations for understanding" 

  • Authors: Aleksandra Vidovich; Amy Williams; Samantha H. Tam; Mary K. Miller; Maria Olex; Sami Nassar; Alex Rodriguez; Eric Adjei Boakye
  • Journal: Cancer Epidemiology, Biomarkers & Prevention
  • Year: 2023

"The Role of ctDNA and Liquid Biopsy in the Diagnosis and Monitoring of Head and Neck Cancer: Towards Precision Medicine"

  • Authors: Sami I. Nassar; Amber Suk; Shaun A. Nguyen, MD; Dauren Adilbay; John Pang; Cherie-Ann Nathan
  • Journal: Cancer
  • Year: 2024